Nicotinamide riboside, or NR, is a vitamin B3-related molecule studied as a precursor to the coenzyme NAD+. It occurs in trace amounts in foods and is also produced commercially. The entry reviews NAD+ metabolism, vascular and muscle function, and metabolic research, without describing an established anti-aging treatment.
What Is NR (Nicotinamide Riboside)?
Nicotinamide riboside, commonly abbreviated NR, is a pyridine-nucleoside form of vitamin B3 composed of nicotinamide linked to ribose. It occurs in trace amounts in some foods and is also produced commercially, frequently as nicotinamide riboside chloride. NR is studied because it can serve as a dietary precursor to nicotinamide adenine dinucleotide, or NAD+, a central coenzyme involved in energy production, redox balance, DNA repair, chromatin regulation, and cellular stress responses.
NAD+ concentrations and the activity of NAD+-dependent enzymes may change with age, tissue type, metabolic state, inflammation, and cellular damage. Oral NR has therefore become a research tool for testing whether increasing NAD+ availability can influence human physiology. Human trials have generally focused on pharmacokinetics, tolerability, blood NAD+ metabolites, skeletal-muscle metabolism, cardiovascular measures, insulin sensitivity, and markers associated with aging. NR is not established as a treatment for aging, disease, fatigue, or any other medical condition, and responses may differ according to baseline NAD+ status, dose, duration, diet, exercise, and health status.
Quick Reference
Member reference tables summarize the compound's research parameters.
Human supplementation studies consistently show increased whole-blood NAD+ and related nicotinamide metabolites after oral NR administration.
Bioavailable NAD+ precursor
NR is converted through the nicotinamide riboside kinase pathway to NMN and NAD+, supporting cellular redox cofactor availability.
Healthy Aging & Vascular Function
Preliminary Data
Blood pressure and arterial stiffness
A small trial in middle-aged and older adults reported signals consistent with reduced systolic blood pressure and improved arterial stiffness, particularly in participants with elevated baseline pressure.
Inflammatory signaling
Human skeletal-muscle data identified transcriptomic changes including anti-inflammatory signatures; clinical relevance remains uncertain.
Exercise & Mitochondrial Function
Emerging Evidence
Mitochondrial outcomes
Despite reliably increasing NAD+ metabolites, controlled human studies have not consistently demonstrated improved skeletal-muscle mitochondrial respiration.
Physical performance
Evidence for improved exercise capacity, strength, or recovery in healthy adults is limited and mixed.
Metabolic Health
Preliminary Data
Insulin sensitivity
Trials in people with insulin resistance or obesity have not established a consistent clinically meaningful benefit for insulin sensitivity or glycemic control.
Body composition
NR should not be considered an evidence-based intervention for weight loss or changes in fat mass.
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.
This member section describes parameters reported in the research literature.
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
This member section discusses research safety considerations and uncertainties.
The described verification process includes looking for a current, lot-matched COA identifying the product, lot number, test date, and quantitative NR result.
Verified Marker
Independent identity and purity testing
Prefer third-party HPLC or LC-MS testing that reports identity confirmation and assay purity rather than a generic in-house statement.
Verified Marker
Contaminant screening
A quality report should include heavy-metal and microbiological testing, with results and method limits rather than unsupported claims.
Acceptable Range
Accurate capsule labeling
The label should state elemental NR quantity per capsule and serving, excipients, capsule material, storage conditions, and expiration date.
Quality Concern
Unverifiable purity or proprietary blends
The listed research text specifies avoiding products without batch documentation, products that obscure NR dose within a blend, or vendors making pharmaceutical-grade claims without evidence.